"New Gene Therapy Brings Hope for Sickle Cell Cure in the US"
Originally Published 1 year ago — by NBC Washington
A 12-year-old boy named Kendric Cromer has become the first patient in the U.S. to undergo a newly approved gene therapy for sickle cell disease at Children's National Hospital in D.C. The treatment, which involves modifying his bone marrow stem cells, offers hope for a potential cure and could transform care for thousands suffering from the debilitating condition. Kendric and his family are optimistic about the future, despite the painful and costly process.